Fig. 2
From: Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
Representative photomicrographs of liver sections stained with Hematoxylin & Eosin (a–c), Sudan III (d–f) and Naphtol AS-D (g–i) in the liver in the control group (C); diabetic and high fat diet mice (HDC); diabetic and high fat diet mice treated with aliskiren (HDA) (× 400 magnification). Graphic representation of steatosis score (j), Sudan III labeling (k), inflammation score (l) and neutrophil influx (m) in C, HDC and HDA groups. *P < 0.05, C × HDC; ●P < 0.05, HDC × HDA. (n = 4–6 mice per group)